Literature DB >> 17635746

Effect of n-3 fatty acids on nutritional status and inflammatory markers in haemodialysis patients.

Gordana B Perunicic-Pekovic1, Zorica R Rasic, Steva I Pljesa, Sladjana S Sobajic, Ivana Djuricic, Radojka Maletic, Danijela K Ristic-Medic.   

Abstract

AIMS: Nutrition as an aetiological factor participates a great deal in premature atherosclerosis in haemodialysis (HD) patients. The basic mechanisms of end-stage renal disease and premature atherosclerosis are connected with changes in cell functions at the membrane level. We investigated the red cell membrane fatty acids and the effects of fish oil supplements on nutritional status and inflammatory markers in HD patients.
METHODS: We examined 42 HD patients (mean age 55 +/- 8 years). The control group consisted of 16 healthy subjects of similar age and sex to the tested group. HD patients were administered supplements with 2.4 g of n-3 polyunsaturated fatty acids per day for 2 months. Before and after supplementation, we examined plasma lipids, cell membrane erythrocyte phospholipids content, serum albumin, haemoglobin, interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-alpha).
RESULTS: Baseline values in the tested group confirmed the presence of essential fatty acids deficiency. A statistically significant negative correlation between TNF-alpha and eicosapentaenoic acid (EPA) (r = -0.497; P < 0.05) and IL-6 and EPA (r = -468; P = 0.03) was found in HD patients before supplementation. There was a significant increase in docosahexaenoic acids, high density lipoprotein cholesterol, plasma albumin, haemoglobin levels in HD patients after supplementation (P = 0.0001). There was a significant increase in EPA (P = 0.01) after treatment, and there was a significant decrease in inflammatory markers (IL-6 and TNF-alpha, P = 0.0001) after supplementation in the tested group.
CONCLUSION: A dietary regime with fish oil could be used in dialysis patients to slow down the development of atherosclerosis and improve nutritional parameters.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17635746     DOI: 10.1111/j.1440-1797.2007.00777.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  18 in total

1.  The impact of fish oil and wheat germ oil combination on mineral-bone and inflammatory markers in maintenance hemodialysis patients: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Hadeer Zakaria; Tarek M Mostafa; Gamal A El-Azab; Ahmed M Abd El Wahab; Heba Elshahawy; Nagy Ah Sayed-Ahmed
Journal:  Int Urol Nephrol       Date:  2017-06-30       Impact factor: 2.370

2.  Effects of Omega-3 Fatty Acids on Markers of Inflammation in Patients With Chronic Kidney Disease: A Controversial Issue.

Authors:  Chun Hu; Ming Yang; Xuejing Zhu; Peng Gao; Shikun Yang; Yachun Han; Xianghui Chen; Li Xiao; Shuguang Yuan; Fuyou Liu; Yashpal S Kanwar; Lin Sun
Journal:  Ther Apher Dial       Date:  2017-12-22       Impact factor: 1.762

3.  Dietary omega-3 fatty acid, ratio of omega-6 to omega-3 intake, inflammation, and survival in long-term hemodialysis patients.

Authors:  Nazanin Noori; Ramanath Dukkipati; Csaba P Kovesdy; John J Sim; Usama Feroze; Sameer B Murali; Rachelle Bross; Debbie Benner; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2011-06-12       Impact factor: 8.860

4.  Relationship between inflammatory cytokines and cardiorenal anemia syndrome: treatment with recombinant human erythropoietin (rhepo).

Authors:  G Perunicic-Pekovic; S Pljesa; Z Rasic; L J Komadina; R Markovic; L J Lambic; D Celeketic
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

5.  Omega-3 fatty acids inhibit the up-regulation of endothelial chemokines in maintenance hemodialysis patients.

Authors:  Adriana M Hung; Cindy Booker; Charles D Ellis; Edward D Siew; Amy J Graves; Ayumi Shintani; Naji N Abumrad; Jonathan Himmelfarb; Talat Alp Ikizler
Journal:  Nephrol Dial Transplant       Date:  2014-09-09       Impact factor: 5.992

6.  The effect of omega-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial.

Authors:  Afshin Gharekhani; Mohammad-Reza Khatami; Simin Dashti-Khavidaki; Effat Razeghi; Ahmad-Ali Noorbala; Seyed-Saeed Hashemi-Nazari; Mohammad-Ali Mansournia
Journal:  Eur J Clin Pharmacol       Date:  2014-03-20       Impact factor: 2.953

7.  Effect of fish oil supplement in maintenance hemodialysis patients: a systematic review and meta-analysis of published randomized controlled trials.

Authors:  Lei He; Meng-si Li; Mei Lin; Tian-ya Zhao; Ping Gao
Journal:  Eur J Clin Pharmacol       Date:  2015-11-12       Impact factor: 2.953

Review 8.  Cardioprotective effects of ω -3 PUFAs in chronic kidney disease.

Authors:  Su Mi Lee; Won Suk An
Journal:  Biomed Res Int       Date:  2013-04-04       Impact factor: 3.411

9.  Effects of protein and omega-3 supplementation, provided during regular dialysis sessions, on nutritional and inflammatory indices in hemodialysis patients.

Authors:  Zulfitri A Mat Daud; Boniface Tubie; Judy Adams; Tracey Quainton; Robert Osia; Sharon Tubie; Deepinder Kaur; Pramod Khosla; Marina Sheyman
Journal:  Vasc Health Risk Manag       Date:  2012-03-20

Review 10.  Eicosapentaenoic Acid as a Potential Therapeutic Approach to Reduce Cardiovascular Risk in Patients with End-Stage Renal Disease on Hemodialysis: A Review.

Authors:  Kenneth M Borow; R Preston Mason; Krishnaswami Vijayaraghavan
Journal:  Cardiorenal Med       Date:  2017-09-16       Impact factor: 2.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.